Evidence map›Paper›PMID 27699760›Full record

SynthesisThe Cochrane database of systematic reviews2016

Intensity of continuous renal replacement therapy for acute kidney injury.

Alicia I Fayad, Daniel G Buamscha, Agustín Ciapponi

Registry-linked trialOpen access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06901011 (Continuous Renal Replacement Therapy Doses in Critically Ill Patients With Acute Kidney Injury), which is not on this map. Cited by 43 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 6 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06901011 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Continuous Renal Replacement Therapy Doses in Critically Ill Patients With Acute Kidney Injury

TypeinterventionalSponsorFundacion Clinic per a la Recerca BiomédicaRan2025 to 2027Enrolled100ConditionsRenal Replacement Therapy for Acute Kidney Injury in ICU, Continuous Renal Replacement Therapy (CRRT)Armscontinuous renal replacement therapy
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 6 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Guideline
  2. Guideline
  3. Pooled it
  4. Timing of kidney replacement therapy initiation for acute kidney injury.The Cochrane database of systematic reviews · 2022
    Pooled it
  5. Timing of renal replacement therapy initiation for acute kidney injury.The Cochrane database of systematic reviews · 2018
    Pooled it
  6. Intensity of continuous renal replacement therapy for acute kidney injury.The Cochrane database of systematic reviews · 2016
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Alveolar macrophages polarization switch via αInflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  13. Observational
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Alicia I FayadPediatric Nephrology, Ricardo Gutierrez Children's Hospital, Institute for Clinical Effectiveness and Health Policy, Los Incas Av 4174, Buenos Aires, Argentina, 1427.
Daniel G Buamscha
Agustín Ciapponi
Consejo Nacional de Investigaciones Científicas y Técnicas · ARGarrahan Hospital · ARHospital General de Niños Ricardo Gutierrez · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) is a common condition among patients in intensive care units (ICU), and is associated with substantial morbidity and mortality. Continuous renal replacement therapy (CRRT) is a blood purification technique used to treat the most severe forms of AKI but its effectiveness remains unclear.

objectivesTo assess the effects of different intensities (intensive and less intensive) of CRRT on mortality and recovery of kidney function in critically ill AKI patients. SEARCH

methodsWe searched Cochrane Kidney and Transplant's Specialised Register to 9 February 2016 through contact with the Information Specialist using search terms relevant to this review. Studies contained in the Specialised Register are identified through search strategies specifically designed for CENTRAL, MEDLINE, and EMBASE; handsearching conference proceedings; and searching the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. We also searched LILACS to 9 February 2016. SELECTION CRITERIA: We included all randomised controlled trials (RCTs). We included all patients with AKI in ICU regardless of age, comparing intensive (usually a prescribed dose ≥35 mL/kg/h) versus less intensive CRRT (usually a prescribed dose < 35 mL/kg/h). For safety and cost outcomes we planned to include cohort studies and non-RCTs. DATA COLLECTION AND ANALYSIS: Data were extracted independently by two authors. The random-effects model was used and results were reported as risk ratios (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes, with 95% confidence intervals (CI). MAIN

resultsWe included six studies enrolling 3185 participants. Studies were assessed as being at low or unclear risk of bias. There was no significant difference between intensive versus less intensive CRRT on mortality risk at day 30 (5 studies, 2402 participants: RR 0.88, 95% CI 0.71 to 1.08; I AUTHORS'

conclusionsBased on the current low quality of evidence identified, more intensive CRRT did not demonstrate beneficial effects on mortality or recovery of kidney function in critically ill patients with AKI. There was an increased risk of hypophosphataemia with more intense CRRT. Intensive CRRT reduced the risk of mortality in patients with post-surgical AKI.

Indexed as

Acute Kidney InjuryHumansHypophosphatemiaLength of StayRandomized Controlled Trials as TopicRecovery of FunctionRenal DialysisRenal Replacement Therapy

Identifiers

PMID27699760
PMCPMC6457961
OpenAlexW1930276441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.